ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17 | +183.3% | 1,500 | +400.0% | 0.00% | – |
| Q2 2023 | $6 | +20.0% | 300 | +147.9% | 0.00% | – |
| Q1 2023 | $5 | -28.6% | 121 | -13.6% | 0.00% | – |
| Q4 2022 | $7 | -99.8% | 140 | +145.6% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | – | 57 | +1800.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 3 | -57.1% | 0.00% | – |
| Q4 2021 | $1,000 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |